4U.S. Department of Health and Human Services FDA Center for Drug Evaluation and Research, U.S. Department of Health and Human Services FDA Center for Biologics Evaluation and Re- search, U.S. Department of Health and Human Services FDA Cen- ter for Devices and Radiological Health. Guidance for industry: patient-reported outcome measures: use in medical product devel- opment to support labeling claims: draft guidance [J]. Health Qual Life Outcomes, 2006, 4: 79.
5Acquadro C, Berzon R, Dubois D, et al. Incorporating the pa- tient's perspective into drug development and communication: an ad hoc task force report of the Patient-Reported Outcomes (PRO) Harmonization Group meeting at the Food and Drug Administra- tion, February 16, 2001 [J]. Value Health, 2001, 6 (5): 522-531.
6Fiscella K, Ransom S, Jean-Pierre P, et al. Patient-reported outcome measures suitable to assessment of patient navigation [J]. Cancer, 2011, 117 (15Suppl): 3603-3617.
7Sloan JA, Halyard MY, Frost MH, et al. The Mayo clinic manuscript series relative to the discussion, dissemination, and operationalization of the food and drug administration guidance on patient-reported outcomes [J]. Value Health, 2007, 10 Suppl 2 (supple2) : S59-S63.
8Shikiar R, Rentz AM. Satisfaction with medication: an overview of conceptual, methodologic, and regulatory issues [J]. Value Health, 2004, 7 (2): 204-215.
9Valderas JM, Alonso J. Patient reported outcome measures: a model-based classification system for research and clinical practice [J]. Qual Life Res, 2008, 17 (9): 1125-1135.
10Turner RR, Quittner AL, Parasuraman BM, et al. Patient-re- ported outcomes: instrument development and selection issues [J]. Value Health, 2007, 10 Suppl 2 (Suppl.2) : S86-S93.
